SEC Info℠ | Home | Search | My Interests | Help | Sign In | Please Sign In | ||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 3/26/24 Safeguard Scientifics Inc. 10-K 12/31/23 76:6.8M RDG Filings/FA |
Document/Exhibit Description Pages Size 1: 10-K Annual Report HTML 1.59M 2: EX-14.1 Code of Ethics HTML 108K 3: EX-21.1 Subsidiaries List HTML 23K 8: EX-97 Clawback Policy re: Recovery of Erroneously HTML 38K Awarded Compensation 4: EX-31.1 Certification -- §302 - SOA'02 HTML 28K 5: EX-31.2 Certification -- §302 - SOA'02 HTML 28K 6: EX-32.1 Certification -- §906 - SOA'02 HTML 23K 7: EX-32.2 Certification -- §906 - SOA'02 HTML 23K 14: R1 Document And Entity Information HTML 86K 15: R2 Consolidated Balance Sheets HTML 127K 16: R3 Consolidated Balance Sheets (Parentheticals) HTML 33K 17: R4 Consolidated Statements of Operations HTML 75K 18: R5 Consolidated Statements of Changes in HTML 72K Shareholders' Equity 19: R6 Consolidated Statements of Cash Flows HTML 92K 20: R7 Note 1 - General HTML 73K 21: R8 Note 2 - Ownership Interests and Advances HTML 77K 22: R9 Note 3 - Acquisitions of Ownership Interests HTML 30K 23: R10 Note 4 - Fair Value Measurements HTML 59K 24: R11 Note 5 - Equity HTML 32K 25: R12 Note 6 - Stock-Based Compensation HTML 80K 26: R13 Note 7 - Employee Benefit Plan HTML 25K 27: R14 Note 8 - Income Taxes HTML 58K 28: R15 Note 9 - Net Income (Loss) Per Share HTML 40K 29: R16 Note 10 - Related Party Transactions HTML 27K 30: R17 Note 11 - Commitments and Contingencies HTML 32K 31: R18 Note 12 - Supplemental Cash Flow Information HTML 25K 32: R19 Note 13 - Segment Reporting HTML 29K 33: R20 Note 14 - Selected Quarterly Financial Information HTML 81K (Unaudited) 34: R21 Note 15 - Subsequent Events HTML 25K 35: R22 Insider Trading Arrangements HTML 30K 36: R23 Significant Accounting Policies (Policies) HTML 100K 37: R24 Note 1 - General (Tables) HTML 44K 38: R25 Note 2 - Ownership Interests and Advances (Tables) HTML 75K 39: R26 Note 4 - Fair Value Measurements (Tables) HTML 56K 40: R27 Note 6 - Stock-Based Compensation (Tables) HTML 71K 41: R28 Note 8 - Income Taxes (Tables) HTML 54K 42: R29 Note 9 - Net Income (Loss) Per Share (Tables) HTML 36K 43: R30 Note 14 - Selected Quarterly Financial Information HTML 79K (Unaudited) (Tables) 44: R31 Note 1 - General (Details Textual) HTML 30K 45: R32 Note 1 - General - Schedule of Restrictions on HTML 29K Cash and Cash Equivalents (Details) 46: R33 Note 1 - General - Schedule of Leases (Details) HTML 53K 47: R34 Note 2 - Ownership Interests and Advances (Details HTML 50K Textual) 48: R35 Note 2 - Ownership Interests and Advances - HTML 36K Schedule of Carrying Value of Ownership Interests (Details) 49: R36 Note 2 - Ownership Interests and Advances - HTML 31K Schedule of Ownership Interests (Details) 50: R37 Note 2 - Ownership Interests and Advances - HTML 73K Schedule of Equity Method Investment Partner Company Results Of Operation (Details) 51: R38 Note 2 - Ownership Interests and Advances - HTML 49K Schedule of Results of Operations (Details) 52: R39 Note 3 - Acquisitions of Ownership Interests HTML 51K (Details Textual) 53: R40 Note 4 - Fair Value Measurements (Details Textual) HTML 25K 54: R41 Note 4 - Fair Value Measurements - Fair Value of HTML 41K Assets and Liabilities Measured On Recurring Basis (Details) 55: R42 Note 5 - Equity (Details Textual) HTML 43K 56: R43 Note 6 - Stock-Based Compensation (Details HTML 73K Textual) 57: R44 Note 6 - Stock-based Compensation - Schedule of HTML 24K Stock-based Compensation Expense (Details) 58: R45 Note 6 - Stock-Based Compensation - Schedule of HTML 59K Stock Options Activity (Details) 59: R46 Note 6 - Stock-Based Compensation - Schedule of HTML 43K Restricted Stock Units Deferred Stock Units and Performance Units (Details) 60: R47 Note 7 - Employee Benefit Plan (Details Textual) HTML 26K 61: R48 Note 8 - Income Taxes (Details Textual) HTML 31K 62: R49 Note 8 - Income Taxes - Schedule of Effective HTML 29K Income Tax Rate Reconciliation (Details) 63: R50 Note 8 - Income Taxes -Schedule of Deferred Tax HTML 42K Assets and Liabilities (Details) 64: R51 Note 8 - Income Taxes - Schedule of Summary of HTML 31K Operating Loss Carryforwards (Details) 65: R52 Note 9 - Net Income (Loss) Per Share (Details HTML 35K Textual) 66: R53 Note 9 - Net Income (Loss) Per Share - HTML 60K Calculations of Net Income (Loss) Per Share (Details) 67: R54 Note 11 - Commitments and Contingencies (Details HTML 36K Textual) 68: R55 Note 12 - Supplemental Cash Flow Information HTML 22K (Details Textual) 69: R56 Note 13 - Segment Reporting (Details Textual) HTML 22K 70: R57 Note 14 - Selected Quarterly Financial Information HTML 71K (Unaudited) - Schedule of Selected Quarterly Financial Information (Unaudited) (Details) 71: R58 Note 15 - Subsequent Events (Details Textual) HTML 32K 73: XML IDEA XML File -- Filing Summary XML 136K 76: XML XBRL Instance -- sfe20231231_10k_htm XML 1.28M 72: EXCEL IDEA Workbook of Financial Report Info XLSX 97K 10: EX-101.CAL XBRL Calculations -- sfe-20231231_cal XML 138K 11: EX-101.DEF XBRL Definitions -- sfe-20231231_def XML 993K 12: EX-101.LAB XBRL Labels -- sfe-20231231_lab XML 870K 13: EX-101.PRE XBRL Presentations -- sfe-20231231_pre XML 1.04M 9: EX-101.SCH XBRL Schema -- sfe-20231231 XSD 170K 74: JSON XBRL Instance as JSON Data -- MetaLinks 373± 600K 75: ZIP XBRL Zipped Folder -- 0001437749-24-009415-xbrl Zip 321K
Exhibit 31.1
CERTIFICATION
I, Mark R. Dow, certify that:
1. |
I have reviewed this Annual Report on Form 10-K of Safeguard Scientifics, Inc.; |
|
|
|
|
2. |
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; |
|
|
|
|
3. |
Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; |
|
|
|
|
4. |
The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: |
|
|
|
|
|
a. |
designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; |
|
|
|
|
b. |
designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; |
|
|
|
|
c. |
evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and |
|
|
|
|
d. |
disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and |
|
|
|
5. |
The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): |
|
|
|
|
|
a. |
all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and |
|
|
|
|
b. |
any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. |
|
|
SAFEGUARD SCIENTIFICS, INC. |
|
|
|
Date: |
March 26, 2024 |
/s/ Mark R. Dow |
|
|
|
|
|
Chief Executive Officer |
|
|
(Principal Executive Officer) |
This ‘10-K’ Filing | Date | Other Filings | ||
---|---|---|---|---|
Filed on: | 3/26/24 | None on these Dates | ||
For Period end: | 12/31/23 | |||
List all Filings |